black market glp-1 Amylin analogues for weight loss: clinical and patent trends GLP-1 Market Growth and Illicit

GLP-1 drugs not only promote weight loss, which is known to reduce breast cancer risk, but they also reduce systemic inflammation, a known contributor to cancer development

These include nausea, vomiting, bloating, diarrhea, and constipation, often linked to how these drugs slow digestion and alter intestinal movement

For example, medications that require rapid absorption, such as certain pain relievers or antibiotics, may become less effective

"It's maddening," said Timothy Caulfield, a professor in the faculty of law and the school of public health and research director of the Health Law Institute at the University of Alberta